Alnylam-Sponsored PBS Medical Stories - PH1: Bonded Hope

(26:41)

Alnylam Pharmaceuticals sponsors CPR webinar, empowering Boston companies with life-saving skills

(24:58)

How do RNAi Therapeutics Treat Disease?

(1:2)

Alnylam - A Rare Disease Company

(44)

RNAi Therapeutics - How this New Class of Medicines Works

(3:27)

The Futurists - Developing a New Class of Medicines

(2:20)

Get to Know Alnylam - The Leader in RNAi Therapeutics

(2:19)

Alnylam Act - No Charge, Third Party Genetic Testing \u0026 Counseling

(1:24)

Alnylam Overview

(2:29)

Biotech Dealmaking with Regeneron's Nouhad Husseini

(1:2:45)

Galien Forum USA 2024 / PANEL 4A - BIG BIOTECH - WHERE IS IT GOING?

(1:56)

ASG Medicare Insurance Webinar August 17, 2024

(1:27:57)

Kidney Week 2024: High-Impact Clinical Trials - 1

(1:50:45)

ICER Midwest CEPAC Public Meeting on Transthyretin Amyloid Cardiomyopathy: Evidence Presentation

(1:20:19)

Ep. 60 - JMM John Maraganore: A higher bar for investment is a credit to biotech

(36:13)

Oxalate and the Kidneys: Primary Hyperoxaluria in Practice

(45:41)

ふたりの私：ポルフィリン症とともに生きる

(25:49)

Clinical trial opens enrollment: shifting the PARADIGM with PrimeC by Alon Ben-Noon

(55:29)

Who We Are: Alnylam's Core Values

(2:39)

Alnylam Pharma and the Science of RNAi

(1:5)

From Possibility to Patients: The Scientific Odyssey - The Dark Ages

(2:53)

How Can Unwanted Proteins Cause or Contribute to Disease?

(57)

What is RNAi and How Do RNAi-based Medicines Work?

(2:32)

What is an RNAi Therapeutic?

(55)

hATTR amyloidosis: The Importance of Genetic Testing

(2:38)

hATTR amyloidosis: Explore Genetic Testing

(2:4)

Trailer - Developing a New Class of Medicines

(2:38)